256 related articles for article (PubMed ID: 24376773)
1. Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes.
Santiago JA; Potashkin JA
PLoS One; 2013; 8(12):e83940. PubMed ID: 24376773
[TBL] [Abstract][Full Text] [Related]
2. Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.
Santiago JA; Scherzer CR; Potashkin JA
PLoS One; 2014; 9(10):e109042. PubMed ID: 25279756
[TBL] [Abstract][Full Text] [Related]
3. System-based approaches to decode the molecular links in Parkinson's disease and diabetes.
Santiago JA; Potashkin JA
Neurobiol Dis; 2014 Dec; 72 Pt A():84-91. PubMed ID: 24718034
[TBL] [Abstract][Full Text] [Related]
4. Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.
Molsberry S; Bjornevik K; Hughes KC; Zhang ZJ; Jeanfavre S; Clish C; Healy B; Schwarzschild M; Ascherio A
J Parkinsons Dis; 2020; 10(3):1011-1021. PubMed ID: 32250318
[TBL] [Abstract][Full Text] [Related]
5. Lipid Metabolism is the common pathologic mechanism between Type 2 Diabetes Mellitus and Parkinson's disease.
Zhang X; Fan Y; Luo Y; Jin L; Li S
Int J Med Sci; 2020; 17(12):1723-1732. PubMed ID: 32714075
[TBL] [Abstract][Full Text] [Related]
6. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
[TBL] [Abstract][Full Text] [Related]
7. Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease.
Santiago JA; Littlefield AM; Potashkin JA
Sci Rep; 2016 Sep; 6():34579. PubMed ID: 27680512
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis for the identification of key candidate genes and pathways in the substantia nigra in Parkinson's disease.
Liu H; Huang Y; Li J
J Integr Neurosci; 2018; 17(3-4):619-631. PubMed ID: 30010140
[TBL] [Abstract][Full Text] [Related]
9. Specific splice variants are associated with Parkinson's disease.
Santiago JA; Scherzer CR; ; Potashkin JA
Mov Disord; 2013 Oct; 28(12):1724-7. PubMed ID: 24108702
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the progression of Parkinson's disease: a metabolic network approach.
Eckert T; Tang C; Eidelberg D
Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682
[TBL] [Abstract][Full Text] [Related]
11. Low-variance RNAs identify Parkinson's disease molecular signature in blood.
Chikina MD; Gerald CP; Li X; Ge Y; Pincas H; Nair VD; Wong AK; Krishnan A; Troyanskaya OG; Raymond D; Saunders-Pullman R; Bressman SB; Yue Z; Sealfon SC
Mov Disord; 2015 May; 30(6):813-21. PubMed ID: 25786808
[TBL] [Abstract][Full Text] [Related]
12. A network approach to diagnostic biomarkers in progressive supranuclear palsy.
Santiago JA; Potashkin JA
Mov Disord; 2014 Apr; 29(4):550-5. PubMed ID: 24347522
[TBL] [Abstract][Full Text] [Related]
13. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
Quadri M; Mandemakers W; Grochowska MM; Masius R; Geut H; Fabrizio E; Breedveld GJ; Kuipers D; Minneboo M; Vergouw LJM; Carreras Mascaro A; Yonova-Doing E; Simons E; Zhao T; Di Fonzo AB; Chang HC; Parchi P; Melis M; Correia Guedes L; Criscuolo C; Thomas A; Brouwer RWW; Heijsman D; Ingrassia AMT; Calandra Buonaura G; Rood JP; Capellari S; Rozemuller AJ; Sarchioto M; Fen Chien H; Vanacore N; Olgiati S; Wu-Chou YH; Yeh TH; Boon AJW; Hoogers SE; Ghazvini M; IJpma AS; van IJcken WFJ; Onofrj M; Barone P; Nicholl DJ; Puschmann A; De Mari M; Kievit AJ; Barbosa E; De Michele G; Majoor-Krakauer D; van Swieten JC; de Jong FJ; Ferreira JJ; Cossu G; Lu CS; Meco G; Cortelli P; van de Berg WDJ; Bonifati V;
Lancet Neurol; 2018 Jul; 17(7):597-608. PubMed ID: 29887161
[TBL] [Abstract][Full Text] [Related]
14. Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.
Santiago JA; Potashkin JA
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2257-62. PubMed ID: 25646437
[TBL] [Abstract][Full Text] [Related]
15. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
[TBL] [Abstract][Full Text] [Related]
16. Identification of distinct blood-based biomarkers in early stage of Parkinson's disease.
Wu Y; Yao Q; Jiang GX; Wang G; Cheng Q
Neurol Sci; 2020 Apr; 41(4):893-901. PubMed ID: 31828678
[TBL] [Abstract][Full Text] [Related]
17. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease.
Madhyastha TM; Askren MK; Zhang J; Leverenz JB; Montine TJ; Grabowski TJ
Brain; 2015 Sep; 138(Pt 9):2672-86. PubMed ID: 26173859
[TBL] [Abstract][Full Text] [Related]
18. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
George G; Valiya Parambath S; Lokappa SB; Varkey J
Gene; 2019 May; 697():67-77. PubMed ID: 30776463
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Gene Expression and Regulatory Network Interaction Data Reveals the Protein Kinase C Family of Serine/Threonine Receptors as a Significant Druggable Target for Parkinson's Disease.
Odumpatta R; Arumugam M
J Mol Neurosci; 2021 Mar; 71(3):466-480. PubMed ID: 32728898
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic profiles in Parkinson's disease.
Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A
Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
